Literature DB >> 11682453

alpha(1)-Adrenoceptor subtypes in the mouse mesenteric artery and abdominal aorta.

Y Yamamoto1, K Koike.   

Abstract

1. Subtypes of alpha(1)-adrenoceptor-mediated contractions to noradrenaline in mouse mesenteric artery and abdominal aorta were examined. 2. In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained. However, the pA(2) value for BMY7378 is significantly lower than the accepted value against the alpha(1D)-adrenoceptor subtype. 3. In the abdominal aorta, it was obtained the regional difference for the sensitivity for noradrenaline. 4. In the upper abdominal aorta, the good correlation for the pA(2) values of the antagonists in the native alpha(1D)-adrenoceptor subtype and pK(i) values in the cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the upper abdominal aorta was obtained, and regression line was close to the line of identity. 5. In the lower abdominal aorta, the good correlation for the reported pK(i) values in the cloned alpha(1a)-adrenoceptor subtype with the pA(2) values estimated in the mouse lower abdominal aorta was obtained, and regression line was close to the line of identity. 6. In conclusion, the present functional data in the mouse suggest that (1) alpha(1D)-like adrenoceptors are present in the mesenteric artery, (2) there is the regional difference for the sensitivity for noradrenaline in the abdominal aorta and (3) noradrenaline evokes the contraction mediated through alpha(1D)-adrenoceptor in the upper abdominal aorta, whereas there is alpha(1A)-adrenoceptor-mediated contraction in the lower abdominal aorta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682453      PMCID: PMC1573042          DOI: 10.1038/sj.bjp.0704350

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

Review 1.  International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.

Authors:  J P Hieble; D B Bylund; D E Clarke; D C Eikenburg; S Z Langer; R J Lefkowitz; K P Minneman; R R Ruffolo
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

Review 2.  Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.

Authors:  J P Hieble; W E Bondinell; R R Ruffolo
Journal:  J Med Chem       Date:  1995-09-01       Impact factor: 7.446

Review 3.  Alpha 1-adrenoceptor classification: sharpening Occam's razor.

Authors:  A P Ford; T J Williams; D R Blue; D E Clarke
Journal:  Trends Pharmacol Sci       Date:  1994-06       Impact factor: 14.819

Review 4.  International Union of Pharmacology nomenclature of adrenoceptors.

Authors:  D B Bylund; D C Eikenberg; J P Hieble; S Z Langer; R J Lefkowitz; K P Minneman; P B Molinoff; R R Ruffolo; U Trendelenburg
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

Review 5.  Classification of alpha 1-adrenoceptor subtypes.

Authors:  M C Michel; B Kenny; D A Schwinn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

6.  The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.

Authors:  C Forray; J A Bard; J M Wetzel; G Chiu; E Shapiro; R Tang; H Lepor; P R Hartig; R L Weinshank; T A Branchek
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

7.  BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors.

Authors:  A S Goetz; H K King; S D Ward; T A True; T J Rimele; D L Saussy
Journal:  Eur J Pharmacol       Date:  1995-01-16       Impact factor: 4.432

8.  Pharmacological evidence of distinct alpha 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery.

Authors:  A Hatano; H Takahashi; M Tamaki; T Komeyama; T Koizumi; M Takeda
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

9.  Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog.

Authors:  R E Link; M S Stevens; M Kulatunga; M Scheinin; G S Barsh; B K Kobilka
Journal:  Mol Pharmacol       Date:  1995-07       Impact factor: 4.436

10.  Targeted disruption of the beta 3-adrenergic receptor gene.

Authors:  V S Susulic; R C Frederich; J Lawitts; E Tozzo; B B Kahn; M E Harper; J Himms-Hagen; J S Flier; B B Lowell
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

View more
  6 in total

1.  Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.

Authors:  Chihiro Hosoda; Akito Tanoue; Mari Shibano; Yoshio Tanaka; Masami Hiroyama; Taka-aki Koshimizu; Susanna Cotecchia; Tadaichi Kitamura; Gozoh Tsujimoto; Katsuo Koike
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

2.  Size-dependent heterogeneity of contractile Ca2+ sensitization in rat arterial smooth muscle.

Authors:  Toshio Kitazawa; Kazuyo Kitazawa
Journal:  J Physiol       Date:  2012-08-28       Impact factor: 5.182

3.  Differential contributions of alpha-1 and alpha-2 adrenoceptors to vasoconstriction in mesenteric arteries and veins of normal and hypertensive mice.

Authors:  Alex A Pérez-Rivera; Alexandra Hlavacova; Leonardo A Rosario-Colón; Gregory D Fink; James J Galligan
Journal:  Vascul Pharmacol       Date:  2007-01-27       Impact factor: 5.773

4.  Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.

Authors:  Jun Wan; Aya Yamamura; Adriana M Zimnicka; Guillaume Voiriot; Kimberly A Smith; Haiyang Tang; Ramon J Ayon; Moumita S R Choudhury; Eun A Ko; Jun Wang; Chen Wang; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-05-17       Impact factor: 5.464

5.  α1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries.

Authors:  Nicla Flacco; Jaime Parés; Eva Serna; Vanessa Segura; Diana Vicente; Miguel Pérez-Aso; María Antonia Noguera; María Dolores Ivorra; John C McGrath; Pilar D'Ocon
Journal:  Pharmacol Res Perspect       Date:  2013-08-28

6.  Translational value of mechanical and vasomotor properties of mouse isolated mesenteric resistance-sized arteries.

Authors:  Emilie M Outzen; Marina Zaki; Bahareh Abdolalizadeh; Anette Sams; Harrie C M Boonen; Majid Sheykhzade
Journal:  Pharmacol Res Perspect       Date:  2015-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.